Fast Five Quiz: Alzheimer's Disease Workup

Jasvinder P. Chawla, MD, MBA; Shaheen E. Lakhan, MD, PhD, MS, MEd


September 08, 2023

Figure 1. Coronal MRI of the brain showing severe generalized atrophy of brain tissue with an accentuated loss of tissue involving the temporal lobes in a patient with advanced Alzheimer's disease.

According to Lakhan and colleagues, the primary goal of the diagnostic criteria established by the National Institute on Aging and the Alzheimer's Association is to facilitate research. For healthcare providers without access to cerebrospinal fluid (CSF) testing or advanced imaging, the National Institute of Neurological Disorders and the Alzheimer's Association propose core clinical criteria to diagnose mild cognitive impairment, as does the American Academy of Neurology. These criteria are primarily clinical, with biomarkers playing a secondary role.

Learn more about the workup of Alzheimer's disease.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.